This inventor holds 10 USPTO granted patents. Top assignees: A. H. Robins Company, Incorporated, American Home Products Corporation, Discovery Therapeutics, Inc.. Active years: 1990-1999.
Location History:
- Chesterfield, VA (US) (1990 - 1991)
- Richmond, VA (US) (1993 - 1999)
Company Filing History:
5 out of 218 
3 out of 1,567 
2 out of 8 Years Active: 1990-1999
Title: Innovations of Ibrahim M Uwaydah
Introduction
Ibrahim M Uwaydah is a notable inventor based in Richmond, VA (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of 10 patents to his name, Uwaydah's work focuses on compounds that have various therapeutic applications.
Latest Patents
Uwaydah's latest patents include the development of substituted 9-alkyladenines. These optically active or racemic compounds are represented by specific chemical formulas, where R1 is a C1 to C4 straight chain or branched alkyl. R2 can be a variety of groups, including H, --OR1, --SR1, and others, while R3 is cyclopentyl or other specified structures. These compounds are particularly useful as diuretics and renal protectives against acute or chronic renal failure. They also facilitate recovery from coma and improve therapeutic outcomes in defibrillation or cardiopulmonary resuscitation. Additionally, they help restore cardiac function following cardioplegic procedures and treat or prevent intermittent claudication.
Career Highlights
Throughout his career, Uwaydah has worked with prominent companies such as A.H. Robins Company, Incorporated and American Home Products Corporation. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Uwaydah has collaborated with notable coworkers, including David A Walsh and Young S Lo. These partnerships have likely enhanced his research and development efforts in the pharmaceutical field.
Conclusion
Ibrahim M Uwaydah's contributions to pharmaceutical innovations through his patents demonstrate his commitment to advancing medical science. His work continues to have a significant impact on therapeutic applications and patient care.